Two drugs have been recalled because their capsules might be empty — and the consequences could be deadly. Astellas Pharma’s Prograf gets prescribed after heart, liver, kidney or lung transplants.

New York, United States , June 13, 2024 (GLOBE NEWSWIRE) -- The Global Empty Capsules Market Size is to Grow from USD 3.17 Billion in 2023 to USD 7.53 Billion by 2033, at a Compound Annual Growth Rate ...

Westford, USA, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Empty Capsules Market size was valued at USD 2.89 billion in 2023 to USD 4.96 billion by 2031, growing at a CAGR of 7% during the forecast period (2024 ...

The company is recalling one lot of PROGRAF 0.5mg (tacrolimus) and one lot of ASTAGRAF XL 0.5mg (tacrolimus extended-release) capsules because some bottles may contain empty capsules. Astellas Pharma ...

Allied Market Research published a report, titled, “Empty Capsules Market by Product (Gelatin Capsules and Non-Gelatin Capsules), Raw Material (Pig Meat, Bovine Meat, Bone, Hydroxypropyl ...

Astellas Pharma US, Inc. (Head of US Commercial: Michael Petroutsas, "Astellas") is voluntarily recalling one lot of PROGRAF® 0.5mg (tacrolimus) and one lot of ASTAGRAF XL® 0.5mg (tacrolimus ...

Advancements in capsule delivery technology, including targeted delivery, controlled release mechanisms, and enhanced bioavailability, are propelling the demand for empty capsules. These innovations ...

Empty capsules are small, cylindrical containers typically made from gelatin or plant-based materials, designed to hold active ingredients in powder, liquid, or pellet form. They serve as a delivery ...

The type of segment is segmented into gelatin and non-gelatin. The gelatin halal empty capsules segment dominated type segments owing to various factors such as availability of bovine gelatin, ...